Generics May Improve Adherence in Breast Cancer Patients, Study Finds
The study, published in the Journal of the National Cancer Institute, found that out-of-pocket costs influenced adherence to hormone therapy in women with HR-positive, early-stage breast cancer.
The Industry’s Dirty Secret: The Data Are Inaccurate
Patient satisfaction may be increasingly important in healthcare, but the industry hasn’t made the appropriate changes yet, 2 employees from Prime Therapeutics said in back-to-back sessions at the 64th Annual Roy A. Bowers Pharmaceutical Conference.
Myriad and Abbvie Deal on Companion Diagnostic Test for Breast Cancer
The BRCAnalysis test will be used in conjunction with Abbvie's novel PARP inhibitor veliparib for the treatment of breast cancer.
In the Literature: microRNA Biomarkers For Early Detection of Childhood Cancers
Research to be presented this week at the National Cancer Research Institute Cancer Conference has identified the expression of specific serum microRNAs in pediatric solid tumors, which could prove useful for early diagnosis.
Supreme Court Passes on ACA Subsidy Case—For Now
At this time, the Supreme Court of the United States has declined to hear an appeal of one of the cases challenging the legality of making subsidies under the Affordable Care Act available to consumers on the federally run health insurance exchanges.
Physician Fee Schedule and Hospital Outpatient Payment System: Updates by CMS
CMS released final rules for both the 2015 Medicare Physician Fee Schedule and the 2015 Hospital Outpatient Prospective Payment System.
Limited Literacy, Numeracy Hurts Those the ACA Is Meant to Help
The Affordable Care Act expanded healthcare coverage to many low-income Americans, but this same demographic has a low health literacy that makes it difficult for them to navigate program eligibility systems, according to a study from The Urban Institute.
California Data Breach Report Underscores Need for Encryption in Healthcare
Seventy percent of breaches involving the California healthcare industry were due to unencrypted data on lost or stolen hardware or portable media, a problem that strong encryption would fix.
Computer-Aided Mammograms Increase Medicare Cost-Burden: JAMA Study
The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.
Diagnostic Lung Biopsies a Big Drain on Medicare, Study Finds
The retrospective study, results of which were presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, showed that the total diagnostic workup cost for the study sample of Medicare beneficiaries was $38.3 million.
Medicare Budget Pinched By Payments for the Departed
An investigation into 2012 Medicare claims for HIV-infected patients unearthed payment for prescriptions that were filled up to 32 days after the patient's passing.
Extending Hospital Stays by One Day Reduces Readmission, Mortality Rates
In 2015, hospital readmissions will be a growing concern as the maximum penalty increases to 3% of Medicare payments. Researcher from Columbia Business School found that one extra day in the hospital can make all the difference to readmission and mortality rates.
Kindred Healthcare Names New CEO
Kindred Healthcare, Inc’s chief operating officer and president, Benjamin A. Breier will take over as chief executive officer next year, just after the company is expected to close its acquisition of Gentiva Health Services.
After Pembrolizumab, Promising Results With Nivolumab in NSCLC
Phase 2 results from the Checkmate-063 trial found that treatment with the PD-1 inhibitor Nivolumab (Opdivo) resulted in a median OS of 8.2 months in NSCLC patients who had received 2 prior treatments.
Report Outlines How to Improve Measures for Accountable Care
Gaps in accountable measure sets exist among some of the most prevalent and costly conditions, according to a new report from the National Pharmaceutical Council and Discern Health.
Healthcare Transformation and the Price of Pharmaceuticals
Panelists discussed the price of pharmaceuticals and controlling the cost of care at the 64th Annual Roy A. Bowers Pharmaceutical Conference: A Measured Approach—Health Care Delivery and Transformation in a Metric Driven World, held by Rutgers University.
EMA Grants Orphan Status to Kiadis Pharma's Immuno-oncology Molecule
The European Medicines Agency granted an orphan status to ATIR, a T-cell immunotherapy-based medicinal product being developed to treat blood cancers.
Mental Health Issues Overshadow Breast Cancer Survivorship
The Danish study, published in the Journal of Clinical Oncology, identified a 70% greater risk of severe depression in the first year after diagnosis.
Test Predicts Benefit of Extended Endocrine Therapy in Breast Cancer Patients
bioTheranostics, Inc’s Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be covered by Medicare.
UnitedHealth Continues Its Acquisition Spree
Optum, UHC's technology and services subsidiary, has bought Allere's wellness subsidiaries.
Increased Incidence of T1DM in Young White Children
The report, published in the journal Diabetes, found that children between 5 to 9 years of age were the hardest hit.
Privately Insured Consumers Spending More on Fewer Medical Services
Despite using fewer medical services, privately insured Americans spent more money on these services in 2013, according to a report from the Health Care Cost Institute. The average enrollee in an employer health plan increased spending by 3.9% last year.
Dr Karen B. DeSalvo Not Leaving ONC Just Yet
The Office of the National Coordinator for Health Information Technology (ONC) seemed to be in dire straits as its leadership slowly left for other jobs. However, despite Dr DeSalvo’s new position within HHS, she will maintain her leadership position in ONC, according to a new report.
Prostate Cancer Screening Remains Highly Debated
While the USPSTF recommended against screening for prostate cancer, citing the high rate of false positives, complications from biopsy, and side-effects of aggressive treatment for a sometimes slowly-progressing disease, several medical organizations disagree.
After Drones and a Smart Eye Device, Google Introduces An Early Disease Tracer
Google is aiming to diagnose cancers, impending heart attacks or strokes and other diseases, at a much earlier stage than is currently possible.